var data={"title":"Moraxella catarrhalis infections","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Moraxella catarrhalis infections</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/contributors\" class=\"contributor contributor_credentials\">Timothy F Murphy, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/contributors\" class=\"contributor contributor_credentials\">John G Bartlett, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/contributors\" class=\"contributor contributor_credentials\">Thomas M File, Jr, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/contributors\" class=\"contributor contributor_credentials\">Sheila Bond, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 08, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1052223437\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>Moraxella catarrhalis</em> is a gram-negative diplococcus that commonly colonizes the upper respiratory tract. It is a leading cause of acute otitis media in children, acute exacerbations of chronic obstructive pulmonary disease (COPD), and acute bacterial rhinosinusitis.</p><p>The epidemiology, pathogenesis, clinical manifestations, diagnosis, treatment, and prevention of infections caused by <em>M. catarrhalis</em> are discussed here.</p><p>Acute otitis media, COPD, and acute rhinosinusitis are discussed separately:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-otitis-media-in-children-epidemiology-microbiology-clinical-manifestations-and-complications\" class=\"medical medical_review\">&quot;Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-otitis-media-in-children-diagnosis\" class=\"medical medical_review\">&quot;Acute otitis media in children: Diagnosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-otitis-media-in-children-treatment\" class=\"medical medical_review\">&quot;Acute otitis media in children: Treatment&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-otitis-media-in-adults\" class=\"medical medical_review\">&quot;Acute otitis media in adults&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=management-of-infection-in-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">&quot;Management of infection in exacerbations of chronic obstructive pulmonary disease&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Clinical features and diagnosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-microbiology-and-treatment\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Microbiology and treatment&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=uncomplicated-acute-sinusitis-and-rhinosinusitis-in-adults-treatment\" class=\"medical medical_review\">&quot;Uncomplicated acute sinusitis and rhinosinusitis in adults: Treatment&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=evaluation-for-infection-in-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">&quot;Evaluation for infection in exacerbations of chronic obstructive pulmonary disease&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H748621531\"><span class=\"h1\">EPIDEMIOLOGY</span></p><p class=\"headingAnchor\" id=\"H3276044025\"><span class=\"h2\">Prevalence and incidence</span></p><p class=\"headingAnchor\" id=\"H2001470055\"><span class=\"h3\">Colonization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Colonization with <em>M. catarrhalis</em> is a predisposing factor for infection, and its prevalence is highly dependent on age [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/1-8\" class=\"abstract_t\">1-8</a>]. In infants, nasopharyngeal colonization with <em>M. catarrhalis </em>is common, with reported prevalence ranging from 30 to 100 percent [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/1-5,9\" class=\"abstract_t\">1-5,9</a>]. By adulthood, prevalence declines to approximately 1 to 5 percent. Among adults with chronic obstructive pulmonary disease (COPD), the prevalence is higher, but precise rates have not been measured [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6\" class=\"abstract_t\">6</a>]. Across age groups, colonization appears to be episodic, with different <em>M. catarrhalis </em>strains colonizing the upper respiratory tract over time [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6,10\" class=\"abstract_t\">6,10</a>].</p><p class=\"headingAnchor\" id=\"H629440075\"><span class=\"h3\">Infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. catarrhalis</em> is among the top three causes of acute otitis media in children, acute exacerbations of COPD, and acute bacterial rhinosinusitis.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Approximately 10 to 20 percent of acute otitis media cases in children are caused by <em>M. catarrhalis</em>, with the highest rates observed in children &lt;24 months old [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/7,8,11,12\" class=\"abstract_t\">7,8,11,12</a>]. In adults, <em>M. catarrhalis </em>is an uncommon cause of otitis media, consistent with the low colonization rate.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Similarly, approximately 10 to 20 percent of acute COPD exacerbations are caused by <em>M. catarrhalis </em>[<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6,13\" class=\"abstract_t\">6,13</a>]<em>.</em></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The great majority of cases of acute rhinosinusitis are viral [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/14\" class=\"abstract_t\">14</a>]. Acute bacterial infections account for only 0.5 to 2 percent of cases. Of those, <em>M. catarrhalis </em>accounts for approximately 5 to 15 percent of cases [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/15\" class=\"abstract_t\">15</a>].</p><p/><p><em>M. catarrhalis</em> is an infrequent cause of other infections, such as community-acquired pneumonia and bacteremia [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/16,17\" class=\"abstract_t\">16,17</a>]. Other invasive infections are rare [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/17-20\" class=\"abstract_t\">17-20</a>]. (See <a href=\"#H1052224630\" class=\"local\">'Pneumonia and invasive infections'</a> below.)</p><p class=\"headingAnchor\" id=\"H1389143487\"><span class=\"h3\">Effect of pneumococcal vaccination</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rates of colonization and infection with <em>M. catarrhalis </em>are rising due to the widespread use of pneumococcal vaccinations, which alter the respiratory tract microbiome. With vaccine use, colonization with vaccine serotypes of <em>Streptococcus pneumoniae</em> generally declines, while colonization with other microorganisms such as <em>M. catarrhalis, Haemophilus influenzae</em>, and nonvaccine <em>S. pneumoniae </em>serotypes rises [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/5,21-29\" class=\"abstract_t\">5,21-29</a>]. Similar changes have been observed in the prevalence of pathogens that cause otitis media and acute rhinosinusitis [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/15,30-37\" class=\"abstract_t\">15,30-37</a>]. Although the rise in prevalence does not appear to be as large for <em>M. catarrhalis </em>when compared with <em>H. influenzae</em>, further changes are expected as newer vaccines are developed and vaccination rates grow.</p><p class=\"headingAnchor\" id=\"H2979024380\"><span class=\"h2\">Transmission</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. catarrhalis </em>is transmitted from person to person, likely via respiratory droplets and fomites [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/38\" class=\"abstract_t\">38</a>]. Clusters of cases have been reported in hospital settings [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/38-41\" class=\"abstract_t\">38-41</a>], daycare centers [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/42\" class=\"abstract_t\">42</a>], and among family members [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/43,44\" class=\"abstract_t\">43,44</a>].</p><p class=\"headingAnchor\" id=\"H1365484576\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. catarrhalis</em> is an aerobic, nonmotile gram-negative diplococcus. The organism is an exclusively human pathogen with an ecologic niche in the upper respiratory tract. The organism belongs to the Moraxellaceae family and <em>Moraxella </em>genus [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/45\" class=\"abstract_t\">45</a>]. Multiple strain types exist within the species, and virulence factors and pathogenic potential vary among strains [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10\" class=\"abstract_t\">10</a>]. Other species within the <em>Moraxella </em>genus are rarely pathogenic in humans, although some colonize the upper respiratory tract and, less often, the skin and urogenital tract [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/46-49\" class=\"abstract_t\">46-49</a>].</p><p class=\"headingAnchor\" id=\"H1971168554\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of <em>M. catarrhalis </em>infections involves complex interactions among viral pathogens, bacterial copathogens, and the host immune response.</p><p>For most infections, the initial step in pathogenesis is adherence to and colonization of mucosal surfaces. <em>M. catarrhalis</em> expresses a dozen or more adhesins, each with different binding specificities for host structures [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10,12,50,51\" class=\"abstract_t\">10,12,50,51</a>]. Following adherence, bacteria invade the respiratory mucosa. Primary cellular targets include the epithelial cells lining the respiratory mucosa, antigen-presenting cells, neutrophils, and lymphocytes [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10,52,53\" class=\"abstract_t\">10,52,53</a>]. Adherence and invasion trigger an excessive proinflammatory immune response, which in turn damages host tissues and promotes spread of the infection [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10,54-57\" class=\"abstract_t\">10,54-57</a>]. The proinflammatory response also leads to the hyperproduction of mucus along the respiratory tract. Certain virulence factors have immune-evasive functions such as inactivation of the complement system [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10,58-61\" class=\"abstract_t\">10,58-61</a>] and inhibition of toll-like receptor 2 signaling. As bacteria aggregate, biofilms can form, which reduce the host's ability to clear the organism and promote resistance to antibiotic therapy [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10,62-64\" class=\"abstract_t\">10,62-64</a>]. In acute otitis media, adherence to the mucosal surface is not sufficient to cause disease [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/65,66\" class=\"abstract_t\">65,66</a>]. A cofactor, such as a viral infection, is likely needed to precipitate migration to the middle ear via the Eustachian tube [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/67\" class=\"abstract_t\">67</a>]. <em>M. catarrhalis</em> is often isolated with <em>S. pneumoniae</em> and <em>H. influenzae</em> in respiratory tract cultures [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/68-70\" class=\"abstract_t\">68-70</a>] and may facilitate polymicrobial infection by sheltering these organisms from complement-mediated immune destruction, promoting biofilm formation, and releasing beta-lactamase into the local environment [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/71-76\" class=\"abstract_t\">71-76</a>]. Similar factors may be involved in the pathogenesis of acute bacterial rhinosinusitis, which is frequently preceded by viral infections and can be polymicrobial. (See <a href=\"topic.htm?path=acute-otitis-media-in-children-epidemiology-microbiology-clinical-manifestations-and-complications#H15\" class=\"medical medical_review\">&quot;Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications&quot;, section on 'Pathogenesis'</a> and <a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis#H3\" class=\"medical medical_review\">&quot;Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis&quot;, section on 'Pathophysiology and microbiology'</a> and <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis#H5\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Clinical features and diagnosis&quot;, section on 'Pathogenesis'</a>.)</p><p>While copathogens likely play a role in the pathogenesis of acute exacerbations of COPD, the acquisition of new <em>M. catarrhalis </em>strains appears to be the critical factor [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/77,78\" class=\"abstract_t\">77,78</a>]. The mucosal surface of the lower respiratory tract in patients with COPD is generally damaged, remodeled, and fibrotic, which facilitate adherence and colonization. The acquisition of a new strain of <em>M. catarrhalis</em> provokes airway inflammation [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/54,79,80\" class=\"abstract_t\">54,79,80</a>], which can result in clinical exacerbations [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6,77\" class=\"abstract_t\">6,77</a>]. With clearance of the new strain, protective antibodies are produced and confer protection against reinfection with the same strain but not with other strains [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6,81-83\" class=\"abstract_t\">6,81-83</a>]. (See <a href=\"topic.htm?path=evaluation-for-infection-in-exacerbations-of-chronic-obstructive-pulmonary-disease#H1395695156\" class=\"medical medical_review\">&quot;Evaluation for infection in exacerbations of chronic obstructive pulmonary disease&quot;, section on 'Etiology'</a>.)</p><p class=\"headingAnchor\" id=\"H1052224084\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The most common clinical manifestations of <em>M. catarrhalis</em> infections are acute otitis media (AOM), acute exacerbations of chronic obstructive pulmonary disease (COPD), and acute rhinosinusitis.</p><p class=\"headingAnchor\" id=\"H1052224091\"><span class=\"h2\">Acute otitis media</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Signs and symptoms of AOM due to <em>M. catarrhalis </em>do not differ substantially from otitis media caused by other pathogens and commonly include fever, ear pain, and a bulging tympanic membrane. However, <em>M. catarrhalis </em>is generally considered to be less virulent than other common otopathogens such as <em>S. pneumoniae </em>and <em>H. influenzae.</em> In a large cohort study evaluating children &lt;5 years old with AOM, complications such as tympanic membrane perforation and mastoiditis occurred less frequently<em> </em>with <em>M. catarrhalis </em>than with <em>S. pneumoniae</em> or <em>H. influenzae</em>.</p><p>AOM caused by <em>M. catarrhalis</em> most often occurs in younger children, especially those under two years old [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/70\" class=\"abstract_t\">70</a>], and is rare in adults. AOM is often preceded by a viral upper respiratory tract infection. Most cases of AOM due to <em>M. catarrhalis</em> occur in late fall to early spring [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/11\" class=\"abstract_t\">11</a>]. The seasonal nature of infection correlates with the incidence of respiratory viral infections, which are probable cofactors in AOM pathogenesis. (See <a href=\"#H1971168554\" class=\"local\">'Pathogenesis'</a> above.)</p><p>The clinical features of acute otitis media in children are discussed in detail separately. (See <a href=\"topic.htm?path=acute-otitis-media-in-children-epidemiology-microbiology-clinical-manifestations-and-complications#H21\" class=\"medical medical_review\">&quot;Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"headingAnchor\" id=\"H1052224362\"><span class=\"h2\">Acute exacerbations of COPD</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The clinical features of acute exacerbations of chronic obstructive pulmonary disease (COPD) caused by <em>M. catarrhalis </em>are similar to those of exacerbations caused by other bacteria. Common symptoms include increased cough, sputum production, sputum purulence (change in color), and dyspnea when compared with baseline. (See <a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging#H5\" class=\"medical medical_review\">&quot;Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging&quot;, section on 'Clinical features'</a>.)</p><p>Persons with COPD are commonly colonized with <em>M. catarrhalis </em>[<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6,13\" class=\"abstract_t\">6,13</a>]. New strains are acquired and cleared from the sputum routinely. In about 50 percent of cases, acquisition of a new strain leads to clinical exacerbation [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6,13,77\" class=\"abstract_t\">6,13,77</a>]. Exacerbations caused by <em>M. catarrhalis</em> occur throughout the year, but more cases occur in late fall to early spring [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/13\" class=\"abstract_t\">13</a>].</p><p class=\"headingAnchor\" id=\"H480888656\"><span class=\"h2\">Acute bacterial rhinosinusitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Signs and symptoms of acute bacterial sinusitis caused by <em>M. catarrhalis</em> are similar to those caused by other bacteria and include fever, nasal obstruction, purulent nasal discharge, facial pain, and headache. There is no clinical feature that helps distinguish acute rhinosinusitis caused by <em>M. catarrhalis</em> from acute rhinosinusitis caused by other bacteria.(See <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis#H7\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Clinical features and diagnosis&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H1052224630\"><span class=\"h2\">Pneumonia and invasive infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span><em>M. catarrhalis</em> is an infrequent cause of other infections. Community-acquired pneumonia due to <em>M. catarrhalis</em> occurs most frequently in older adults, persons with cardiopulmonary disease or diabetes mellitus, <span class=\"nowrap\">and/or</span> immunocompromised persons [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/16,84,85\" class=\"abstract_t\">16,84,85</a>].</p><p>Invasive infections caused by <em>M. catarrhalis </em>are rare [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/17-20\" class=\"abstract_t\">17-20</a>]. A 2007 review of the literature reported only 75 cases of invasive infection; these included bacteremia, endocarditis, pneumonia, periorbital cellulitis, neonatal meningitis, and septic arthritis [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/17\" class=\"abstract_t\">17</a>]. Seventy-two of the 75 patients (96 percent) had bacteremia. Invasive infections have been reported across age groups and in both immunocompromised and immunocompetent patients [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/17,86\" class=\"abstract_t\">17,86</a>]. Although no clear risk factors for invasive infection have been identified, a small case-control study detected an increased rate of bacteremia in children with transnasal devices such as nasogastric tubes [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/87\" class=\"abstract_t\">87</a>].</p><p class=\"headingAnchor\" id=\"H1052224666\"><span class=\"h1\">DIAGNOSIS</span></p><p class=\"headingAnchor\" id=\"H247940740\"><span class=\"h2\">Clinical diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Characteristic clinical features usually are sufficient for diagnosis of the most common clinical syndromes caused by <em>M. catarrhalis</em>:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute otitis media is typically diagnosed by visualization of a bulging tympanic membrane on pneumatic otoscopy [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/88\" class=\"abstract_t\">88</a>]. Symptoms that support the diagnosis include ear pain and fever. (See <a href=\"topic.htm?path=acute-otitis-media-in-children-diagnosis#H20\" class=\"medical medical_review\">&quot;Acute otitis media in children: Diagnosis&quot;, section on 'Clinical diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute exacerbations of chronic obstructive pulmonary disease (COPD) are characterized by an increase in baseline dyspnea, cough, and sputum production. The presence of purulent sputum raises the likelihood of a bacterial cause. (See <a href=\"topic.htm?path=evaluation-for-infection-in-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">&quot;Evaluation for infection in exacerbations of chronic obstructive pulmonary disease&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Acute rhinosinusitis is characterized by fever, nasal obstruction, nasal discharge, facial pain, and headache. The presence of prolonged symptoms or symptoms that improve but then get better (double worsening) raise the likelihood of a bacterial cause. (See <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Clinical features and diagnosis&quot;</a> and <a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis&quot;</a>.)</p><p/><p>For most patients, pursuing a microbiologic diagnosis usually is unnecessary because testing can be invasive (eg, tympanocentesis for otitis media), treatment is empiric, and results generally do not change management.</p><p class=\"headingAnchor\" id=\"H1095986278\"><span class=\"h2\">Microbiologic diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Microbiologic testing is generally reserved for patients with acute otitis media or acute bacterial rhinosinusitis who have failed empiric antibiotic therapy, patients with severe COPD exacerbations, or patients who may otherwise benefit from directed antibiotic therapy.</p><p>Microbiologic diagnosis is made by Gram stain and culture of the organism from the affected site. On Gram stain, <em>M. catarrhalis</em> appears as a gram-negative diplococcus that is morphologically similar to <em>Neisseria </em>species (<a href=\"image.htm?imageKey=ID%2F74078\" class=\"graphic graphic_picture graphicRef74078 \">picture 1</a>). Because <em>Neisseria </em>spp are a normal part of the upper respiratory tract flora, some microbiology laboratories do not proceed to culture when organisms that look like <em>Neisseria</em> spp are identified. In such cases, a specific request to culture the organism may be needed.</p><p>In culture, the organism grows as round, opaque colonies on blood and chocolate agar, which typically turn pink after 48 hours. The &quot;hockey puck sign&quot; (the ability of colonies to slide across agar without disruption) is characteristic feature of <em>M. catarrhalis</em>. In most laboratories, antibiotic susceptibility testing is not routinely performed but can be requested when there is a need for precise targeted antibiotic therapy.</p><p>The abundance of <em>M. catarrhalis </em>detected<em> </em>on Gram stain or culture may also have diagnostic value (eg, heavy growth on sputum culture in a patient with an acute COPD exacerbation suggests <em>M. catarrhalis</em> infection rather than colonization).</p><p>Molecular assays for the detection of <em>M. catarrhalis</em>, such as polymerase chain reaction, are in development but not yet commercially available [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/89-91\" class=\"abstract_t\">89-91</a>].</p><p class=\"headingAnchor\" id=\"H528736984\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of <em>M. catarrhalis</em> infection varies with the site of involvement but generally includes other pathogens that commonly colonize or infect the upper respiratory tract such as <em>S. pneumoniae</em>, <em>H. influenzae</em>, and respiratory viruses. There are no characteristic clinical features that help distinguish infection caused by <em>M. catarrhalis</em> from infection caused by other pathogens.</p><p class=\"headingAnchor\" id=\"H1052224713\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most cases of acute otitis media, acute chronic obstructive pulmonary disease (COPD) exacerbations, and acute bacterial rhinosinusitis are treated empirically. (See <a href=\"topic.htm?path=acute-otitis-media-in-children-treatment#H10\" class=\"medical medical_review\">&quot;Acute otitis media in children: Treatment&quot;, section on 'Initial antimicrobial therapy'</a> and <a href=\"topic.htm?path=acute-otitis-media-in-adults#H17\" class=\"medical medical_review\">&quot;Acute otitis media in adults&quot;, section on 'Treatment'</a> and <a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-microbiology-and-treatment#H3\" class=\"medical medical_review\">&quot;Acute bacterial rhinosinusitis in children: Microbiology and treatment&quot;, section on 'Empiric antibiotic therapy'</a> and <a href=\"topic.htm?path=uncomplicated-acute-sinusitis-and-rhinosinusitis-in-adults-treatment\" class=\"medical medical_review\">&quot;Uncomplicated acute sinusitis and rhinosinusitis in adults: Treatment&quot;</a>.)</p><p>When directed therapy is needed, the selection of an agent depends on the clinical syndrome, the severity of infection, the susceptibility pattern of the organism (if known), and patient drug intolerances and comorbidities. <em>M. catarrhalis</em> is generally susceptible to the following antibiotics or antibiotic classes [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/36,46,92\" class=\"abstract_t\">36,46,92</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">Amoxicillin-clavulanate</a></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">Trimethoprim-sulfamethoxazole</a></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cephalosporins</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Macrolides</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tetracyclines</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Fluoroquinolones</p><p/><p>Selecting among these agents based on individual patient characteristics is a reasonable approach to treatment. However, it should be noted that resistance to macrolides and tetracyclines has been reported in Asia. Although <em>M. catarrhalis</em> is also routinely susceptible to <a href=\"topic.htm?path=piperacillin-united-states-not-available-drug-information\" class=\"drug drug_general\">piperacillin</a>, ticarcillin, and aminoglycosides, most <em>M. catarrhalis </em>infections do not require intravenous antibiotics [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/46\" class=\"abstract_t\">46</a>].</p><p>Nearly all strains of <em>M. catarrhalis</em> produce beta-lactamase and are resistant to penicillin, <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">ampicillin</a>, and <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">amoxicillin</a> [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/93-96\" class=\"abstract_t\">93-96</a>]. <em>M. catarrhalis</em> is also resistant to <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a> and <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a> [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/46\" class=\"abstract_t\">46</a>]. These agents should not be used for treatment.</p><p class=\"headingAnchor\" id=\"H432138274\"><span class=\"h1\">PREVENTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>No vaccines are commercially available. However, several candidate vaccines are in development [<a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/50,97-100\" class=\"abstract_t\">50,97-100</a>].</p><p class=\"headingAnchor\" id=\"H1052224888\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>Moraxella catarrhalis</em> is a gram-negative diplococcus that commonly colonizes and infects the respiratory tract. Rates of infection with <em>M. catarrhalis </em>are rising due to the widespread use of pneumococcal vaccinations, which alter the respiratory tract microbiome. (See <a href=\"#H748621531\" class=\"local\">'Epidemiology'</a> above and <a href=\"#H1052223437\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common clinical manifestations of <em>M. catarrhalis</em> infections are acute otitis media in children, acute exacerbations of chronic obstructive pulmonary disease (COPD) in adults, and acute rhinosinusitis. Less common manifestations include pneumonia and bacteremia. Other invasive infections are rare. (See <a href=\"#H1052224084\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There are no characteristic clinical features that distinguish infections caused by <em>M. catarrhalis</em> from other bacterial pathogens, although <em>M. catarrhalis</em> tends to be more common in late fall to early spring compared with other times of the year. (See <a href=\"#H1052224084\" class=\"local\">'Clinical manifestations'</a> above and <a href=\"#H528736984\" class=\"local\">'Differential diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The most common infections caused by <em>M. catarrhalis</em> are diagnosed clinically. Microbiologic diagnosis can be made by culture but is not routinely performed because testing can be invasive (eg, tympanocentesis for otitis media); treatment is empiric, and results usually do not change management. (See <a href=\"#H247940740\" class=\"local\">'Clinical diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pursuing a microbiologic diagnosis is generally reserved for patients with acute otitis media or acute bacterial rhinosinusitis who have failed empiric antibiotic therapy, patients with severe COPD exacerbations, or patients who may otherwise benefit from directed antibiotic therapy. (See <a href=\"#H1095986278\" class=\"local\">'Microbiologic diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antibiotic treatment for most cases of acute otitis media, acute COPD exacerbations, and acute bacterial rhinosinusitis is empiric. (See <a href=\"#H1052224713\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When directed therapy for <em>M. catarrhalis</em> is needed, the selection of an agent depends on the site and severity of infection, the susceptibility pattern of the organism, and patient drug intolerances and comorbidities. (See <a href=\"#H1052224713\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><em>M. catarrhalis</em> is generally susceptible to <a href=\"topic.htm?path=amoxicillin-and-clavulanate-drug-information\" class=\"drug drug_general\">amoxicillin-clavulanate</a>, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>, extended-spectrum cephalosporins, macrolides, tetracyclines, and fluoroquinolones, although resistance to macrolides and tetracyclines has been reported in Asia.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Most <em>M. catarrhalis </em>strains are resistant to penicillin, <a href=\"topic.htm?path=amoxicillin-drug-information\" class=\"drug drug_general\">amoxicillin</a>, <a href=\"topic.htm?path=ampicillin-drug-information\" class=\"drug drug_general\">ampicillin</a>, <a href=\"topic.htm?path=vancomycin-drug-information\" class=\"drug drug_general\">vancomycin</a>, and <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>No vaccines targeting <em>M. catarrhalis</em> are commercially available. However, several candidate vaccines are in development. (See <a href=\"#H432138274\" class=\"local\">'Prevention'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/1\" class=\"nounderline abstract_t\">Ejlertsen T, Thisted E, Ebbesen F, et al. Branhamella catarrhalis in children and adults. A study of prevalence, time of colonisation, and association with upper and lower respiratory tract infections. J Infect 1994; 29:23.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/2\" class=\"nounderline abstract_t\">Faden H, Harabuchi Y, Hong JJ. Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis 1994; 169:1312.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/3\" class=\"nounderline abstract_t\">Aniansson G, Alm B, Andersson B, et al. Nasopharyngeal colonization during the first year of life. J Infect Dis 1992; 165 Suppl 1:S38.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/4\" class=\"nounderline abstract_t\">Leach AJ, Boswell JB, Asche V, et al. Bacterial colonization of the nasopharynx predicts very early onset and persistence of otitis media in Australian aboriginal infants. Pediatr Infect Dis J 1994; 13:983.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/5\" class=\"nounderline abstract_t\">Navne JE, B&oslash;rresen ML, Slotved HC, et al. Nasopharyngeal bacterial carriage in young children in Greenland: a population at high risk of respiratory infections. Epidemiol Infect 2016; 144:3226.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/6\" class=\"nounderline abstract_t\">Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 2005; 172:195.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/7\" class=\"nounderline abstract_t\">Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis 2006; 43:1417.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/8\" class=\"nounderline abstract_t\">Coker TR, Chan LS, Newberry SJ, et al. Diagnosis, microbial epidemiology, and antibiotic treatment of acute otitis media in children: a systematic review. JAMA 2010; 304:2161.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/9\" class=\"nounderline abstract_t\">Vaneechoutte M, Verschraegen G, Claeys G, et al. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol 1990; 28:2674.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/10\" class=\"nounderline abstract_t\">Su YC, Singh B, Riesbeck K. Moraxella catarrhalis: from interactions with the host immune system to vaccine development. Future Microbiol 2012; 7:1073.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/11\" class=\"nounderline abstract_t\">Kilpi T, Herva E, Kaijalainen T, et al. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J 2001; 20:654.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/12\" class=\"nounderline abstract_t\">Murphy TF, Parameswaran GI. Moraxella catarrhalis, a human respiratory tract pathogen. Clin Infect Dis 2009; 49:124.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/13\" class=\"nounderline abstract_t\">Wilkinson TMA, Aris E, Bourne S, et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax 2017; 72:919.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/14\" class=\"nounderline abstract_t\">Rosenfeld RM. CLINICAL PRACTICE. Acute Sinusitis in Adults. N Engl J Med 2016; 375:962.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/15\" class=\"nounderline abstract_t\">Brook I, Gober AE. Frequency of recovery of pathogens from the nasopharynx of children with acute maxillary sinusitis before and after the introduction of vaccination with the 7-valent pneumococcal vaccine. Int J Pediatr Otorhinolaryngol 2007; 71:575.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/16\" class=\"nounderline abstract_t\">Cheepsattayakorn A, Tharavichitakul P, Dettrairat S, Sutachai V. Moraxella catarrhalis pneumonia in an AIDS patient: a case report. J Med Assoc Thai 2009; 92:284.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/17\" class=\"nounderline abstract_t\">Tolentino LF. Causes of Moraxella catarrhalis pathogenicity: review of literature and hospital epidemiology. Lab Med 2007; 38:420.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/18\" class=\"nounderline abstract_t\">Shahani L, Tavakoli Tabasi S. Moraxella catarrhalis bacteraemia and prosthetic valve endocarditis. BMJ Case Rep 2015; 2015.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/19\" class=\"nounderline abstract_t\">Sano N, Matsunaga S, Akiyama T, et al. Moraxella catarrhalis bacteraemia associated with prosthetic vascular graft infection. J Med Microbiol 2010; 59:245.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/20\" class=\"nounderline abstract_t\">Ioannidis JP, Worthington M, Griffiths JK, Snydman DR. Spectrum and significance of bacteremia due to Moraxella catarrhalis. Clin Infect Dis 1995; 21:390.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/21\" class=\"nounderline abstract_t\">Bosch AATM, van Houten MA, Bruin JP, et al. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. Vaccine 2016; 34:531.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/22\" class=\"nounderline abstract_t\">Pichichero ME. Ten-Year Study of Acute Otitis Media in Rochester, NY. Pediatr Infect Dis J 2016; 35:1027.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/23\" class=\"nounderline abstract_t\">Vesikari T, Forsten A, Sepp&auml; I, et al. Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland. J Pediatric Infect Dis Soc 2016; 5:237.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/24\" class=\"nounderline abstract_t\">Yildirim I, Little BA, Finkelstein J, et al. Surveillance of pneumococcal colonization and invasive pneumococcal disease reveals shift in prevalent carriage serotypes in Massachusetts' children to relatively low invasiveness. Vaccine 2017; 35:4002.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/25\" class=\"nounderline abstract_t\">Oikawa J, Ishiwada N, Takahashi Y, et al. Changes in nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among healthy children attending a day-care centre before and after official financial support for the 7-valent pneumococcal conjugate vaccine and H. influenzae type b vaccine in Japan. J Infect Chemother 2014; 20:146.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/26\" class=\"nounderline abstract_t\">Dunne EM, Manning J, Russell FM, et al. Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol 2012; 50:1034.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/27\" class=\"nounderline abstract_t\">Andrade DC, Borges IC, Bouzas ML, et al. 10-valent pneumococcal conjugate vaccine (PCV10) decreases metabolic activity but not nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae. Vaccine 2017; 35:4105.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/28\" class=\"nounderline abstract_t\">van Gils EJ, Veenhoven RH, Rodenburg GD, et al. Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine 2011; 29:7595.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/29\" class=\"nounderline abstract_t\">Kaur R, Morris M, Pichichero ME. Epidemiology of Acute Otitis Media in the Postpneumococcal Conjugate Vaccine Era. Pediatrics 2017; 140.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/30\" class=\"nounderline abstract_t\">Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 2004; 23:829.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/31\" class=\"nounderline abstract_t\">Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 2004; 23:824.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/32\" class=\"nounderline abstract_t\">Revai K, McCormick DP, Patel J, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal bacterial colonization during acute otitis media. Pediatrics 2006; 117:1823.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/33\" class=\"nounderline abstract_t\">Brook I, Gober AE. Recovery of interfering and beta-lactamase-producing bacteria from group A beta-haemolytic streptococci carriers and non-carriers. J Med Microbiol 2006; 55:1741.</a></li><li class=\"breakAll\">Casey JR, Kauer R, Pichichero ME. Otopathogens Causing Acute Otitis Media in the 13-Valent Pneumococcal Conjugate Vaccine Era. 18th International Symposium on Recent Advances in Otitis Media; National Harbor, MD. 2015.</li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/35\" class=\"nounderline abstract_t\">Sillanp&auml;&auml; S, Oikarinen S, Sipil&auml; M, et al. Moraxella catarrhalis Might Be More Common than Expected in Acute Otitis Media in Young Finnish Children. J Clin Microbiol 2016; 54:2373.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/36\" class=\"nounderline abstract_t\">Sillanp&auml;&auml; S, Sipil&auml; M, Hy&ouml;ty H, et al. Antibiotic resistance in pathogens causing acute otitis media in Finnish children. Int J Pediatr Otorhinolaryngol 2016; 85:91.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/37\" class=\"nounderline abstract_t\">Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/38\" class=\"nounderline abstract_t\">Qin L, Masaki H, Gotoh K, et al. Molecular epidemiological study of Moraxella catarrhalis isolated from nosocomial respiratory infection patients in a community hospital in Japan. Intern Med 2009; 48:797.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/39\" class=\"nounderline abstract_t\">Masaki H, Asoh N, Kawazoe K, et al. Possible relationship of PFGE patterns of Moraxella catarrhalis between hospital- and community-acquired respiratory infections in a community hospital. Microbiol Immunol 2003; 47:379.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/40\" class=\"nounderline abstract_t\">Ikram RB, Nixon M, Aitken J, Wells E. A prospective study of isolation of Moraxella catarrhalis in a hospital during the winter months. J Hosp Infect 1993; 25:7.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/41\" class=\"nounderline abstract_t\">Calder MA, Croughan MJ, McLeod DT, Ahmad F. The incidence and antibiotic susceptibility of Branhamella catarrhalis in respiratory infections. Drugs 1986; 31 Suppl 3:11.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/42\" class=\"nounderline abstract_t\">Yano H, Suetake M, Kuga A, et al. Pulsed-field gel electrophoresis analysis of nasopharyngeal flora in children attending a day care center. J Clin Microbiol 2000; 38:625.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/43\" class=\"nounderline abstract_t\">Masaki H, Qin L, Zhou Z, et al. A prospective study of intrafamilial transmission and antimicrobial susceptibility of Moraxella catarrhalis. Microbiol Immunol 2011; 55:599.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/44\" class=\"nounderline abstract_t\">Watanabe H, Hoshino K, Sugita R, et al. Molecular analysis of intrafamiliar transmission of Moraxella catarrhalis. Int J Med Microbiol 2005; 295:187.</a></li><li class=\"breakAll\">National Center for Biotechnology InformationTaxonomy Browser. https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi (Accessed on November 07, 2017).</li><li class=\"breakAll\">Murphy TF. Moraxella catarrhalis, Kingella, and other gram-negative cocci. In: Mandell, Douglas, and Bennett's Principles and Practices of Infectious Diseases, 7th ed, Mandell GL, Bennett JE, Dolin R (Eds), Churchill Livingstone Elsevier, Philadelphia 2010. Vol 2, p.2771.</li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/47\" class=\"nounderline abstract_t\">Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001; 85:842.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/48\" class=\"nounderline abstract_t\">Das S, Constantinou M, Daniell M, Taylor HR. Moraxella keratitis: predisposing factors and clinical review of 95 cases. Br J Ophthalmol 2006; 90:1236.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/49\" class=\"nounderline abstract_t\">Laukeland H, Bergh K, Bevanger L. Posttrabeculectomy endophthalmitis caused by Moraxella nonliquefaciens. J Clin Microbiol 2002; 40:2668.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/50\" class=\"nounderline abstract_t\">Tan TT, Riesbeck K. Current progress of adhesins as vaccine candidates for Moraxella catarrhalis. Expert Rev Vaccines 2007; 6:949.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/51\" class=\"nounderline abstract_t\">Singh B, Alvarado-Kristensson M, Johansson M, et al. The Respiratory Pathogen Moraxella catarrhalis Targets Collagen for Maximal Adherence to Host Tissues. MBio 2016; 7:e00066.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/52\" class=\"nounderline abstract_t\">Slevogt H, Seybold J, Tiwari KN, et al. Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response. Cell Microbiol 2007; 9:694.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/53\" class=\"nounderline abstract_t\">Heiniger N, Spaniol V, Troller R, et al. A reservoir of Moraxella catarrhalis in human pharyngeal lymphoid tissue. J Infect Dis 2007; 196:1080.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/54\" class=\"nounderline abstract_t\">Parameswaran GI, Wrona CT, Murphy TF, Sethi S. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease. BMC Infect Dis 2009; 9:178.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/55\" class=\"nounderline abstract_t\">Slevogt H, Schmeck B, Jonatat C, et al. Moraxella catarrhalis induces inflammatory response of bronchial epithelial cells via MAPK and NF-kappaB activation and histone deacetylase activity reduction. Am J Physiol Lung Cell Mol Physiol 2006; 290:L818.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/56\" class=\"nounderline abstract_t\">N'Guessan PD, Temmesfeld-Wollbr&uuml;ck B, Zahlten J, et al. Moraxella catarrhalis induces ERK- and NF-kappaB-dependent COX-2 and prostaglandin E2 in lung epithelium. Eur Respir J 2007; 30:443.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/57\" class=\"nounderline abstract_t\">Slevogt H, Maqami L, Vardarowa K, et al. Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms. Eur Respir J 2008; 31:725.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/58\" class=\"nounderline abstract_t\">Nordstr&ouml;m T, Blom AM, Tan TT, et al. Ionic binding of C3 to the human pathogen Moraxella catarrhalis is a unique mechanism for combating innate immunity. J Immunol 2005; 175:3628.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/59\" class=\"nounderline abstract_t\">Attia AS, Ram S, Rice PA, Hansen EJ. Binding of vitronectin by the Moraxella catarrhalis UspA2 protein interferes with late stages of the complement cascade. Infect Immun 2006; 74:1597.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/60\" class=\"nounderline abstract_t\">Bootsma HJ, van der Heide HG, van de Pas S, et al. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits. J Infect Dis 2000; 181:1376.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/61\" class=\"nounderline abstract_t\">Wirth T, Morelli G, Kusecek B, et al. The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis. Genome Res 2007; 17:1647.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/62\" class=\"nounderline abstract_t\">Hall-Stoodley L, Hu FZ, Gieseke A, et al. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 2006; 296:202.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/63\" class=\"nounderline abstract_t\">Perez AC, Pang B, King LB, et al. Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo. Pathog Dis 2014; 70:280.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/64\" class=\"nounderline abstract_t\">Torretta S, Marchisio P, Drago L, et al. Nasopharyngeal biofilm-producing otopathogens in children with nonsevere recurrent acute otitis media. Otolaryngol Head Neck Surg 2012; 146:991.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/65\" class=\"nounderline abstract_t\">Pettigrew MM, Gent JF, Pyles RB, et al. Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection. J Clin Microbiol 2011; 49:3750.</a></li><li class=\"breakAll\">Murphy TF. Moraxella catarrhalis, Kingella, and other gram-negative cocci. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 8th ed, Bennett JE, Dolin R, Blaser MJ (Eds), Elsevier Inc, Philadelphia, PA 2015. p.2463.</li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/67\" class=\"nounderline abstract_t\">Ruohola A, Pettigrew MM, Lindholm L, et al. Bacterial and viral interactions within the nasopharynx contribute to the risk of acute otitis media. J Infect 2013; 66:247.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/68\" class=\"nounderline abstract_t\">Verhaegh SJ, Snippe ML, Levy F, et al. Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae. Microbiology 2011; 157:169.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/69\" class=\"nounderline abstract_t\">Pettigrew MM, Gent JF, Revai K, et al. Microbial interactions during upper respiratory tract infections. Emerg Infect Dis 2008; 14:1584.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/70\" class=\"nounderline abstract_t\">Broides A, Dagan R, Greenberg D, et al. Acute otitis media caused by Moraxella catarrhalis: epidemiologic and clinical characteristics. Clin Infect Dis 2009; 49:1641.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/71\" class=\"nounderline abstract_t\">Tan TT, Morgelin M, Forsgren A, Riesbeck K. Haemophilus influenzae survival during complement-mediated attacks is promoted by Moraxella catarrhalis outer membrane vesicles. J Infect Dis 2007; 195:1661.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/72\" class=\"nounderline abstract_t\">Armbruster CE, Hong W, Pang B, et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. MBio 2010; 1.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/73\" class=\"nounderline abstract_t\">Hol C, Van Dijke EE, Verduin CM, et al. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia. J Infect Dis 1994; 170:1613.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/74\" class=\"nounderline abstract_t\">Budhani RK, Struthers JK. Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system. Antimicrob Agents Chemother 1998; 42:2521.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/75\" class=\"nounderline abstract_t\">Brook I. Direct and indirect pathogenicity of Branhamella catarrhalis. Drugs 1986; 31 Suppl 3:97.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/76\" class=\"nounderline abstract_t\">Wardle JK. Branhamella catarrhalis as an indirect pathogen. Drugs 1986; 31 Suppl 3:93.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/77\" class=\"nounderline abstract_t\">Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347:465.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/78\" class=\"nounderline abstract_t\">Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359:2355.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/79\" class=\"nounderline abstract_t\">Sethi S, Wrona C, Eschberger K, et al. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:491.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/80\" class=\"nounderline abstract_t\">Sethi S, Muscarella K, Evans N, et al. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 2000; 118:1557.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/81\" class=\"nounderline abstract_t\">LaFontaine ER, Snipes LE, Bullard B, et al. Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis. Clin Vaccine Immunol 2009; 16:653.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/82\" class=\"nounderline abstract_t\">Murphy TF, Brauer AL, Aebi C, Sethi S. Identification of surface antigens of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect Immun 2005; 73:3471.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/83\" class=\"nounderline abstract_t\">Murphy TF, Brauer AL, Aebi C, Sethi S. Antigenic specificity of the mucosal antibody response to Moraxella catarrhalis in chronic obstructive pulmonary disease. Infect Immun 2005; 73:8161.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/84\" class=\"nounderline abstract_t\">Wright PW, Wallace RJ Jr. Pneumonia due to Moraxella (Branhamella) catarrhalis. Semin Respir Infect 1989; 4:40.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/85\" class=\"nounderline abstract_t\">Ariza-Prota MA, Pando-Sandoval A, Garc&iacute;a-Clemente M, et al. Community-Acquired Moraxella catarrhalis Bacteremic Pneumonia: Two Case Reports and Review of the Literature. Case Rep Pulmonol 2016; 2016:5134969.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/86\" class=\"nounderline abstract_t\">Ahmed A, Broides A, Givon-Lavi N, et al. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children. Pediatr Infect Dis J 2008; 27:459.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/87\" class=\"nounderline abstract_t\">Funaki T, Inoue E, Miyairi I. Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study. BMC Infect Dis 2016; 16:73.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/88\" class=\"nounderline abstract_t\">Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. Pediatrics 2013; 131:e964.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/89\" class=\"nounderline abstract_t\">Post JC, Preston RA, Aul JJ, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 1995; 273:1598.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/90\" class=\"nounderline abstract_t\">Hendolin PH, Paulin L, Ylikoski J. Clinically applicable multiplex PCR for four middle ear pathogens. J Clin Microbiol 2000; 38:125.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/91\" class=\"nounderline abstract_t\">Johansson N, Kalin M, Tiveljung-Lindell A, et al. Etiology of community-acquired pneumonia: increased microbiological yield with new diagnostic methods. Clin Infect Dis 2010; 50:202.</a></li><li class=\"breakAll\">Schreckenberger PC, Daneshvar MI, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative gram-negative rods. In: Manual of Clinical Microbiology, 9th ed, Murray PR, Baron EJ, Landry ML, et al (Eds), ASM Press, Washington DC 2007. Vol 1, p.770.</li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/93\" class=\"nounderline abstract_t\">Nissinen A, Gr&ouml;nroos P, Huovinen P, et al. Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis 1995; 21:1193.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/94\" class=\"nounderline abstract_t\">Yamada K, Arai K, Saito R. Antimicrobial susceptibility to &beta;-lactam antibiotics and production of BRO &beta;-lactamase in clinical isolates of Moraxella catarrhalis from a Japanese hospital. J Microbiol Immunol Infect 2017; 50:386.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/95\" class=\"nounderline abstract_t\">Esel D, Ay-Altintop Y, Yagmur G, et al. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis. Clin Microbiol Infect 2007; 13:1023.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/96\" class=\"nounderline abstract_t\">Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program. J Glob Antimicrob Resist 2016; 5:36.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/97\" class=\"nounderline abstract_t\">Murphy TF. Vaccine development for Moraxella catarrhalis: rationale, approaches and challenges. Expert Rev Vaccines 2009; 8:655.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/98\" class=\"nounderline abstract_t\">Ruckdeschel EA, Kirkham C, Lesse AJ, et al. Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection. Infect Immun 2008; 76:1599.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/99\" class=\"nounderline abstract_t\">Perez AC, Murphy TF. Potential impact of a Moraxella catarrhalis vaccine in COPD. Vaccine 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/moraxella-catarrhalis-infections/abstract/100\" class=\"nounderline abstract_t\">Perez AC, Murphy TF. A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges. Hum Vaccin Immunother 2017; 13:2322.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 17122 Version 15.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1052224888\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1052223437\" id=\"outline-link-H1052223437\">INTRODUCTION</a></li><li><a href=\"#H748621531\" id=\"outline-link-H748621531\">EPIDEMIOLOGY</a><ul><li><a href=\"#H3276044025\" id=\"outline-link-H3276044025\">Prevalence and incidence</a><ul><li><a href=\"#H2001470055\" id=\"outline-link-H2001470055\">- Colonization</a></li><li><a href=\"#H629440075\" id=\"outline-link-H629440075\">- Infection</a></li><li><a href=\"#H1389143487\" id=\"outline-link-H1389143487\">- Effect of pneumococcal vaccination</a></li></ul></li><li><a href=\"#H2979024380\" id=\"outline-link-H2979024380\">Transmission</a></li></ul></li><li><a href=\"#H1365484576\" id=\"outline-link-H1365484576\">MICROBIOLOGY</a></li><li><a href=\"#H1971168554\" id=\"outline-link-H1971168554\">PATHOGENESIS</a></li><li><a href=\"#H1052224084\" id=\"outline-link-H1052224084\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H1052224091\" id=\"outline-link-H1052224091\">Acute otitis media</a></li><li><a href=\"#H1052224362\" id=\"outline-link-H1052224362\">Acute exacerbations of COPD</a></li><li><a href=\"#H480888656\" id=\"outline-link-H480888656\">Acute bacterial rhinosinusitis</a></li><li><a href=\"#H1052224630\" id=\"outline-link-H1052224630\">Pneumonia and invasive infections</a></li></ul></li><li><a href=\"#H1052224666\" id=\"outline-link-H1052224666\">DIAGNOSIS</a><ul><li><a href=\"#H247940740\" id=\"outline-link-H247940740\">Clinical diagnosis</a></li><li><a href=\"#H1095986278\" id=\"outline-link-H1095986278\">Microbiologic diagnosis</a></li></ul></li><li><a href=\"#H528736984\" id=\"outline-link-H528736984\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H1052224713\" id=\"outline-link-H1052224713\">TREATMENT</a></li><li><a href=\"#H432138274\" id=\"outline-link-H432138274\">PREVENTION</a></li><li><a href=\"#H1052224888\" id=\"outline-link-H1052224888\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/17122|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/74078\" class=\"graphic graphic_picture\">- Moraxella catarrhalis Gram stain</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-clinical-features-and-diagnosis\" class=\"medical medical_review\">Acute bacterial rhinosinusitis in children: Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-bacterial-rhinosinusitis-in-children-microbiology-and-treatment\" class=\"medical medical_review\">Acute bacterial rhinosinusitis in children: Microbiology and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-otitis-media-in-adults\" class=\"medical medical_review\">Acute otitis media in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-otitis-media-in-children-diagnosis\" class=\"medical medical_review\">Acute otitis media in children: Diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-otitis-media-in-children-epidemiology-microbiology-clinical-manifestations-and-complications\" class=\"medical medical_review\">Acute otitis media in children: Epidemiology, microbiology, clinical manifestations, and complications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-otitis-media-in-children-treatment\" class=\"medical medical_review\">Acute otitis media in children: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-obstructive-pulmonary-disease-definition-clinical-manifestations-diagnosis-and-staging\" class=\"medical medical_review\">Chronic obstructive pulmonary disease: Definition, clinical manifestations, diagnosis, and staging</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-for-infection-in-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">Evaluation for infection in exacerbations of chronic obstructive pulmonary disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-infection-in-exacerbations-of-chronic-obstructive-pulmonary-disease\" class=\"medical medical_review\">Management of infection in exacerbations of chronic obstructive pulmonary disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=uncomplicated-acute-sinusitis-and-rhinosinusitis-in-adults-treatment\" class=\"medical medical_review\">Uncomplicated acute sinusitis and rhinosinusitis in adults: Treatment</a></li></ul></div></div>","javascript":null}